Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2016 Oct 10;34(29):3499-3501.
doi: 10.1200/JCO.2016.67.8938.

Prostate-Specific Antigen Screening: Time to Change the Dominant Forces on the Pendulum

Jonathan E Shoag  1 , Peter N Schlegel  1 , Jim C Hu  1
Affiliations
Editorial

Prostate-Specific Antigen Screening: Time to Change the Dominant Forces on the Pendulum

Jonathan E Shoag et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Figures

Fig A1.
Fig A1.
Depiction of the increase in prostate-specific antigen (PSA) testing that occurred between the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial initial design and recruitment phases (modified from a depiction of men born from 1920 to 1924 in Mariotto AB et al: Cancer 109:1877-1886, 2007).
Fig A2.
Fig A2.
Health Status Questionnaire as it relates to prostate-specific antigen (PSA) screening. Blue shading indicates responses that were counted as testing in the 2009 trial report. All other responses were not counted as testing. (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Men's Health Status Questionnaire. 2005. https://biometry.nci.nih.gov/app_media/cdas-bioshare/documents/studies/plco/forms/HSM.pdf).
See this image and copyright information in PMC

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet. 2014;384:2027–2035. - PMC - PubMed
    1. Andriole GL, Crawford ED, Grubb RL, III, et al. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality results after 13 years of follow-up. J Natl Cancer Inst. 2012;104:125–132. - PMC - PubMed
    1. Andriole GL, Crawford ED, Grubb RL, III, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360:1310–1319. - PMC - PubMed
    1. Penson DF. The pendulum of prostate cancer screening. JAMA. 2015;314:2031–2033. - PubMed
    1. Moyer VA, U.S. Preventive Services Task Force Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:120–134. - PubMed

Substances